Source: Annual Congress 2006 - New features of paediatric asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. P. Brand, A. Baatenburg de Jong, A. F. J. Brouwer, R. J. Roorda (Zwolle, Netherlands). Normal lung function and absence of bronchodilator response in children with stable, controlled asthma using inhaled corticosteroids. Eur Respir J 2006; 28: Suppl. 50, 942

Member's Comments

No comment yet.

Related content which might interest you: The effect of nebulised MgSO4 on lung function in stable severe asthma patients with persistent airflow limitation Source: Annual Congress 2007 - New drugs for asthma Year: 2007 FEF25-75% should not yet be used to define a bronchodilator response in individuals Source: Annual Congress 2005 - Spirometry - now and in the future Year: 2005 Maintenance plus as-needed budesonide/formoterol vs salmeterol/fluticasone in a real-life setting Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005 Salmeterol/fluticasone combination product (SFC) provides better asthma control compared to high dose fluticasone (FP) in symptomatic patients with asthma Source: Annual Congress 2005 - Combination therapy for asthma. Which, why and how? Year: 2005 Airway calibre variability by forced oscillation technique: a sensitive indicator of bronchodilator effect in asthmatic children Source: Annual Congress 2005 - Monitoring paediatric asthma Year: 2005 How to interpret reduced forced expiratory volume in 1 s (FEV1)/vital capacity ratio with normal FEV1 Source: Eur Respir J 2009; 33: 1396-1402 Year: 2009 Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone Source: Eur Respir J 2003; 21: 123-128 Year: 2003 Analysis of the post bronchodilator forced expiratory volume in one second of COPD patients clinically followed up for three years Source: Annual Congress 2013 –COPD diagnosis Year: 2013 The role of concomitant respiratory diseases on the rate of decline in FEV1 among adult asthmatics Source: Eur Respir J 2003; 21: 95-10 Year: 2003 Closing volume predicts the FEV1 response to bronchodilators in patients with COPD Source: Virtual Congress 2020 – Advances in lung function testing Year: 2020 Improvement in asthma control by using leukotriene receptor antagonists: results of an experience-based report in Swiss medical practice Source: Annual Congress 2006 - New developments in the treatment and management of asthma Year: 2006 NVA237, a once-daily anticholinergic, demonstrates sustained bronchodilation and is well tolerated in patients with reversible obstructive airways disease Source: Annual Congress 2006 - Recent advances in the treatment of COPD Year: 2006 Airway resistance variability and response to bronchodilator in children with asthma Source: Eur Respir J 2007; 30: 260-268 Year: 2007 FEV6 or FVC to detect airway obstruction in the community setting? Source: Annual Congress 2007 - PG17 - Lung function measurement in the community Year: 2007 Evaluation of the response of airway obstruction to short-acting inhaled broncodilators with using FIV1 and FEV1 in COPD patients Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 Early life origins of adult lung function Source: Annual Congress 2006 - Highlights of epidemiology of COPD and lung function Year: 2006 Oral or inhaled corticosteroids for patients with chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=281 Year: 2006 Effect of inhaled steroids on lung function in young children: a cohort study Source: Eur Respir J 2004; 23: 869-875 Year: 2004 Indacaterol, a novel inhaled β2-agonist, provides sustained 24-h bronchodilation in asthma Source: Eur Respir J 2007; 29: 871-878 Year: 2007